Skip to Content
Merck
  • Near-infrared fluorescence sentinel lymph node biopsy in vulvar cancer: a randomised comparison of lymphatic tracers.

Near-infrared fluorescence sentinel lymph node biopsy in vulvar cancer: a randomised comparison of lymphatic tracers.

BJOG : an international journal of obstetrics and gynaecology (2013-02-20)
B E Schaafsma, F P R Verbeek, A A W Peters, J R van der Vorst, C D de Kroon, M I E van Poelgeest, J B M Z Trimbos, C J H van de Velde, J V Frangioni, A L Vahrmeijer, K N Gaarenstroom
ABSTRACT

This study aims to confirm the feasibility of near-infrared (NIR) fluorescence imaging for sentinel lymph node (SLN) biopsy in vulvar cancer and to compare the tracer indocyanine green (ICG) bound to human serum albumin (HSA) versus ICG alone. Women received 99mTc-nanocolloid and patent blue for SLN detection. Subsequently, women randomly received ICG:HSA or ICG alone. In 24 women, 35 SLNs were intraoperatively detected. All SLNs detected were radioactive and NIR fluorescent and 27 (77%) were blue. No significant difference was found between ICG:HSA and ICG alone. This trial confirms the feasibility of NIR fluorescence imaging for SLN mapping in vulvar cancer.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Cardiogreen, for microscopy
Sigma-Aldrich
Cardiogreen, polymethine dye